We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$16.8M
(+11%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
11.58%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
254
New
38
Increased
43
Reduced
118
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$3.61M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$3.1M |
| 3 |
Axsome Therapeutics
AXSM
|
+$2.73M |
| 4 |
Pfizer
PFE
|
+$2.64M |
| 5 |
TRML
Tourmaline Bio
TRML
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$3.78M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.13M |
| 3 |
ABVX
Abivax
ABVX
|
+$2.86M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$2.8M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.45% |
| 2 | Real Estate | 11.2% |
| 3 | Financials | 4.6% |
| 4 | Industrials | 3.92% |
| 5 | Technology | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Apollo Global Management
APO
$70.7B
| $110K | 0.07% |
975
-128
| -12% | -$13.5K |
|
177
Synchrony
SYF
$23.7B
| $110K | 0.07% |
2,541
-330
| -11% | -$13.1K |
|
178
Celanese
CE
$5.09B
| $109K | 0.07% |
633
-84
| -12% | -$12.8K |
|
|
BNY
179
Bank of New York Mellon
BNY
$108B
| $105K | 0.06% |
+1,830
| New | +$101K |
|
180
Arista Networks
ANET
$219B
| $105K | 0.06% |
+1,452
| New | +$97.9K |
|
181
Viridian Therapeutics
VRDN
$2.13B
| $105K | 0.06% |
+6,000
| New | +$116K |
|
182
Humana
HUM
$46.7B
| $103K | 0.06% |
297
-40
| -12% | -$15.2K |
|
183
Assurant
AIZ
$13.7B
| $100K | 0.06% |
533
-71
| -12% | -$12.4K |
|
184
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $100K | 0.06% |
920
+217
| +31% | +$23.6K |
|
185
Star Holdings Shares of Beneficial Interest
STHO
$112M
| $100K | 0.06% |
7,744
| – | – |
|
186
Schwab US TIPS ETF
SCHP
$16.3B
| $99.7K | 0.06% |
3,824
+1,186
| +45% | +$30.8K |
|
187
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
| $99.4K | 0.06% |
1,939
+465
| +32% | +$23.8K |
|
188
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$479M
| $99.2K | 0.06% |
2,481
+626
| +34% | +$25.1K |
|
189
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
| $99.1K | 0.06% |
3,213
+781
| +32% | +$24K |
|
190
iShares National Muni Bond ETF
MUB
$45.1B
| $98.7K | 0.06% |
917
+216
| +31% | +$23.3K |
|
191
Jabil
JBL
$32.8B
| $98.6K | 0.06% |
736
-99
| -12% | -$13.3K |
|
192
Tapestry
TPR
$28.8B
| $96.6K | 0.06% |
2,035
-278
| -12% | -$11.9K |
|
193
Hyatt Hotels
H
$17.6B
| $94.5K | 0.06% |
592
-80
| -12% | -$11.3K |
|
194
Tenet Healthcare
THC
$20.1B
| $92.7K | 0.06% |
882
-119
| -12% | -$10.7K |
|
195
Comcast
CMCSA
$79.1B
| $92.3K | 0.06% |
2,130
-277
| -12% | -$11.9K |
|
196
iShares MSCI Indonesia ETF
EIDO
$476M
| $89K | 0.05% |
+3,951
| New | +$88.6K |
|
197
TechnipFMC
FTI
$30.6B
| $83.1K | 0.05% |
3,311
-448
| -12% | -$9.43K |
|
198
EQT Corp
EQT
$33.2B
| $83K | 0.05% |
2,240
-295
| -12% | -$10.6K |
|
199
Coupang
CPNG
$27.8B
| $77.2K | 0.05% |
4,337
-586
| -12% | -$9.59K |
|
200
First Citizens BancShares
FCNCA
$24.6B
| $75.2K | 0.05% |
46
-7
| -13% | -$10.5K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, AlphaCentric Advisors held 254 positions worth $166M, up 11% from $149M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $19.2M of net new capital in Q1 2024, opening 38 new positions and adding to 43 existing holdings. Its largest new stake was United Therapeutics: 16,000 shares worth $3.68M.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Invesco NASDAQ 100 ETF, an estimated $1.72M trimmed.
- AlphaCentric Advisors's largest Q1 2024 buy was United Therapeutics: 16,000 shares worth $3.68M.
- AlphaCentric Advisors added most to Inari Medical, Inc. Common Stock in Q1 2024, an estimated $3.1M increase.
- AlphaCentric Advisors's biggest Q1 2024 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $1.72M.
- AlphaCentric Advisors fully exited Immunogen Inc in Q1 2024, selling an estimated $3.78M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $166M portfolio in Q1 2024.
- AlphaCentric Advisors opened 38 new positions and closed 26 in Q1 2024.
- AlphaCentric Advisors's portfolio value rose 11% quarter-over-quarter to $166M.
Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.